Search Orphan Drug Designations and Approvals
-
Generic Name: | lintuzumab |
---|---|
Date Designated: | 09/09/2002 |
Orphan Designation: | Treatment of acute myelogenous leukemia |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Protein Design Labs, Inc. 34801 Campus Drive Fremont, California 94555 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-